Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 156 participants.

Also called NCT05928936

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose basic science
Phase
Phase 2
Enrolled
  • 156 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05928936
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05928936. Randomized; quadruple masking; primary purpose basic science. Start 2022-11-11 (actual); primary completion 2028-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
Intervention (Drug)
Sodium Bicarbonate
Intervention (Behavioral)
Exercise Training
Intervention (Drug)
Placebo
Lead sponsor
Emory University (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05928936
Content hash
cba2778f0ed3cb621e6c38db425a672db165e00ca67a83f4acf002b82b49f789